RecruitingNCT05408247
N-acetylcysteine or placebo for people with alcohol use disorder
About this title
Read the official source — NCT05408247Researchers are comparing N-acetyl cysteine and placebo to find out how the approaches affect alcohol use in people with alcohol dependence.
Medication studyAges 18–70AustraliaAddiction
Understand this study
What is this study about?
Researchers are comparing N-acetyl cysteine and placebo to find out how the approaches affect alcohol use in people with alcohol dependence.
Who could participate?
Listed age limits: 18 years to 70 years.
What will I do during this study?
Participants are assigned by chance to take N-acetylcysteine or a matching placebo (an inactive comparison treatment) for 12 weeks. In both groups, participants take two capsules by mouth twice a day and receive standard medical management.
- Listed locations
- Sydney and 2 more locationsSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: February 16, 2023
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 280
- Sponsor
- University of Sydney
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Australia
- Age range
- From 18 Years to 70 Years
- Official registry ID
- NCT05408247
- Official title
Show the full official title
A Randomised Controlled Trial of N-acetylcysteine for the Management of Alcohol Use Disorder
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Sydney · Annerley · Richmond
Interested in joining this study?
Questions about this study
What is this study about?
Researchers are comparing N-acetyl cysteine and placebo to find out how the approaches affect alcohol use in people with alcohol dependence.
Who is behind this study?
The study sponsor is University of Sydney, a university.
Does this study involve medication?
Yes. The study involves medication, including N-acetyl cysteine and Placebo.
Who can participate?
Listed age limits: 18 years to 70 years.
Is this study still recruiting?
The registry lists this study as recruiting.
Want to explore more studies?
Explore studiesRelated studies
An open label study to evaluate the safety, tolerability, and subjective effects of two dimethyltryptamine (DMT) and harmala alkaloid containing formulations in healthy volunteers
Guanfacine extended-release or placebo for cannabis use in adolescents